ARCHIVES

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 6 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

NCI clinical trials cooperative group chairmen reject specimen bank contract proposal, endorse cooperative agreements;

January 2, 2004

Cancer Groups In Campaign To Draft Pazdur For FDA.

March 2, 2001

White House Seek Elimination Of NCI’s Bypass Budget Authority In Legislation Renewing Cancer Act

April 9, 1982

In Brief: Curran Moves From Fox Chase To Jefferson; Groundbreaking From UNC Lineberger Center

December 2, 1994

President’s Budget Request for FDA Omits Funding for Critical Path.

February 8, 2008

DCT Issues Two Pas for Small/Exploratory Grants For Clinical, Laboratory Studies

March 23, 1994